(Q40521524)

English

The cyclolignan PPP induces activation loop-specific inhibition of tyrosine phosphorylation of the insulin-like growth factor-1 receptor. Link to the phosphatidyl inositol-3 kinase/Akt apoptotic pathway

scientific article published on October 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 September 2017

The cyclolignan PPP induces activation loop-specific inhibition of tyrosine phosphorylation of the insulin-like growth factor-1 receptor. Link to the phosphatidyl inositol-3 kinase/Akt apoptotic pathway (English)

1 reference

Europe PubMed Central

21 September 2017

apoptotic process

0 references

phosphorylation

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Daiana Vasilcanu

1

1 reference

Europe PubMed Central

21 September 2017

Ada Girnita

2

1 reference

Europe PubMed Central

21 September 2017

Leonard Girnita

3

1 reference

Europe PubMed Central

21 September 2017

Radu Vasilcanu

4

1 reference

Europe PubMed Central

21 September 2017

Magnus Axelson

5

1 reference

Europe PubMed Central

21 September 2017

Olle Larsson

6

1 reference

Europe PubMed Central

21 September 2017

language of work or name

0 references

publication date

1 October 2004

1 reference

Europe PubMed Central

21 September 2017

1 reference

Europe PubMed Central

21 September 2017

23

1 reference

Europe PubMed Central

21 September 2017

47

1 reference

Europe PubMed Central

21 September 2017

7854-7862

1 reference

Europe PubMed Central

21 September 2017

https://scigraph.springernature.com/pub.10.1038/sj.onc.1208065

0 references

Structure and function of the type 1 insulin-like growth factor receptor.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208065

21 January 2018

The IGF-I receptor in cancer research

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208065

21 January 2018

The contradictions of the insulin-like growth factor 1 receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208065

21 January 2018

Substrate competitive inhibitors of IGF-1 receptor kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208065

21 January 2018

Development of new insulin-like growth factor-1 receptor kinase inhibitors using catechol mimics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208065

21 January 2018

PARP-1, a determinant of cell survival in response to DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208065

21 January 2018

Cooperative regulation of the invasive and metastatic phenotypes by different domains of the type I insulin-like growth factor receptor beta subunit

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208065

21 January 2018

Inhibition of the type I insulin-like growth factor receptor expression and signaling: novel strategies for antimetastatic therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208065

21 January 2018

Thermal chemistry of podophyllotoxin in ethanol and a comparison of the cytostatic activity of the thermolysis products

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208065

21 January 2018

Partial activation of the insulin receptor kinase domain by juxtamembrane autophosphorylation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208065

21 January 2018

Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208065

21 January 2018

Structure and autoregulation of the insulin-like growth factor 1 receptor kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208065

21 January 2018

Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208065

21 January 2018

Mdm2-dependent ubiquitination and degradation of the insulin-like growth factor 1 receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208065

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208065

21 January 2018

Current status of the molecular mechanisms of anticancer drug-induced apoptosis. The contribution of molecular-level analysis to cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208065

21 January 2018

Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208065

21 January 2018

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208065

21 January 2018

Molecular and cellular aspects of the insulin-like growth factor I receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208065

21 January 2018

Inhibition of endosomal insulin-like growth factor-I processing by cysteine proteinase inhibitors blocks receptor-mediated functions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208065

21 January 2018

Mechanism-based design of a protein kinase inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208065

21 January 2018

Specific inhibition of insulin-like growth factor-1 and insulin receptor tyrosine kinase activity and biological function by tyrphostins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208065

21 January 2018

The IGF-I receptor in mitogenesis and transformation of mouse embryo cells: role of receptor number

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208065

21 January 2018

Single tyrosine substitution in the insulin-like growth factor I receptor inhibits ligand-induced receptor autophosphorylation and internalization, but not mitogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208065

21 January 2018

Characterization of insulin-like growth factor I (IGF-I) receptor mutants for their effects on IGF-I- and interleukin 4-mediated DNA synthesis of 32D cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208065

21 January 2018

Role of the insulin-like growth factor family in cancer development and progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208065

21 January 2018

Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208065

21 January 2018

Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208065

21 January 2018

Tamoxifen-induced cell death in malignant melanoma cells: possible involvement of the insulin-like growth factor-1 (IGF-1) pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208065

21 January 2018

An antibody to the receptor for insulin-like growth factor I inhibits the growth of MCF-7 cells in tissue culture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208065

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.ONC.1208065

1 reference

Europe PubMed Central

21 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40521524&oldid=1899859406"